Halozyme Therapeutics Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $2.53B
Liabilities Breakdown FY2025
Total Liabilities: $2.48B
Asset Breakdown
Total Assets: $2.53B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $133.8M | 5.3% |
| Accounts Receivable | $426.3M | 16.9% |
| Inventory | $176.5M | 7.0% |
| Property, Plant & Equipment | $44.4M | 1.8% |
| Goodwill | $580.4M | 23.0% |
| Intangible Assets | $981.5M | 38.9% |
| Other Assets | $182.5M | 7.2% |
Liabilities Breakdown
Total Liabilities: $2.48B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $20.9M | 0.8% |
| Long-Term Debt | $2.14B | 86.5% |
| Other Liabilities | $313.0M | 12.6% |